Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

U.S. Markets for Heart Valve Disorder Management Products

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

September 22, 2016

Find out more

U.S. Markets for Interventional Cardiology Products, April 2016

$4,750.00

In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S.

April 1, 2016

Find out more

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies

$4,750.00

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. interventional peripheral vascular disease management arena.

September 22, 2016

Find out more

U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products

$4,750.00

Diagnostic interventional cardiology procedures covered by the scope of this report include electrocardiography (ECG); non-invasive imaging systems including computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, ultrasound, and X-ray

September 22, 2016

Find out more

U.S. Markets for Minimally Invasive Benign Prostatic Hyperplasia and Prostatitis Therapies

$4,750.00

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunites in the benign uterine condition therapy systems market, including global endometrial ablation systems, MR-guided focused ultrasound systems, uterine artery embolization systems, and hysteroscopes/fibroid removal systems.

November 14, 2015

Find out more

U.S. Markets for Neurosurgical and Neurointerventional Products

$3,750.00

This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market.

September 22, 2016

Find out more

U.S. Markets for Obesity Drugs & Devices

$5,250.00

U.S. Markets for Obesity Drugs & Devices

September 22, 2016

Find out more

U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening

$3,750.00

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic ultrasound, minimally invasive biopsy, and tissue screening products arena.

September 22, 2016

Find out more

U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

$4,750.00

Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases.

September 22, 2016

Find out more

U.S. Markets for Orthopedic Biomaterials for Bone Repair and Regeneration

$3,750.00

The United States (U.S.) market for orthopedic biomaterials for bone repair and regeneration, as covered by the scope of this report

May 1, 2013

Find out more

U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration

$3,750.00

The United States (U.S.) market for orthopedic biomaterials, as covered by the scope of this report, comprises bioresorbable fixation devices, visco supplementation products, cartilage repair and regeneration technologies.

July 1, 2013

Find out more

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

$5,250.00

The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury.

September 1, 2015

Find out more

U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management

$4,750.00

More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually.

April 4, 2016

Find out more

U.S. Markets for Respiratory Care Products

$4,750.00

The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.9 billion in 2015, and is expected to climb at a rate of 7% over the forecast period.

June 20, 2016

Find out more

U.S. Markets for Respiratory Care Products, June 2016

$4,750.00

The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.4 billion in 2015.

June 20, 2016

Find out more

MedTech analysis

U.S. Markets for Heart Valve Disorder Management Products

U.S. Markets for Interventional Cardiology Products, April 2016

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies

U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products

U.S. Markets for Minimally Invasive Benign Prostatic Hyperplasia and Prostatitis Therapies

U.S. Markets for Neurosurgical and Neurointerventional Products

U.S. Markets for Obesity Drugs & Devices

U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening

U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

U.S. Markets for Orthopedic Biomaterials for Bone Repair and Regeneration

U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management

U.S. Markets for Respiratory Care Products

U.S. Markets for Respiratory Care Products, June 2016